Sotatercept Use in a Patient with Pulmonary Arterial Hypertension Undergoing Lung Transplantation

Sotatercept Use in a Patient with Pulmonary Arterial Hypertension Undergoing Lung Transplantation

Pulmonary arterial hypertension (PAH) is one of the common indications for lung transplantation. Sotatercept is a new medication with a novel mechanism of action and was recently approved for the treatment of PAH. Sotatercept is associated with significant adverse effects including thrombocytopenia...

Full description

Saved in:
Bibliographic Details
Main Authors: Justin P. Rosenheck, Kashika Goyal, Tara Fallah, Pamela Burcham, Kukbin Choi, Matthew Henn, Elie Homsy, Scott Visovatti, Veronica Franco
Format: Article
Language:English
Published: Elsevier 2025-05-01
Series:JHLT Open
Subjects:
Pulmonary Arterial Hypertension
PAH
Group 1
Lung Transplant
Sotatercept
Online Access:http://www.sciencedirect.com/science/article/pii/S2950133425000084
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items